Genetic abnormalities are a cornerstone for prognostic assessment in multiple myeloma (MM) and form the basis of contemporary risk-stratification systems. In routine clinical practice, cytogenetic karyotyping, fluorescence in situ hybridization, and next-gener... ...

请注册登录后继续浏览